In breast cancer cells, neuropilin-1 receptor (Nrp1) (Bai et al., 2019), membrane protein receptor-related protein (LRP) (Depau et al., 2017), GRPR (Wang et al., 2016), human epidermal growth factor receptor 2 (HER-2) (Shi et al., 2018), VEGFR1 (Aldughaim et al., 2020), etc. Are frequently overexpressed. Here, ERBB2 is linked to breast carcinoma.